Prospective, Single-Center, Phase II Study to Standardize the Mitotane Dosing Regimen in Combination with Platinum-Based Chemotherapy in the First-Line Treatment for Adrenocortical Cancer. (2026). Voprosy Onkologii, 72(1), OF-2404. https://doi.org/10.37469/0507-3758-2026-72-1-OF-2404